Evidence map›Paper›PMID 35404029›Full record

ArticleCellular oncology (Dordrecht, Netherlands)2022

Spheroid-induced heterogeneity and plasticity of uveal melanoma cells.

Yao Chen, Xiaoqin Lu, Ling Gao, Douglas C Dean, Yongqing Liu

Open access · hybridAbstract read
In one paragraph

Article in Cellular oncology (Dordrecht, Netherlands), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Role of ZEB1 in angiogenesis and therapeutic potential (Review).International journal of molecular medicine · 2026
    Review
  2. The latestExpert opinion on drug discovery · 2026
    Review
  3. Review
  4. ZEB1 and Uveal Melanoma Invasiveness.International journal of molecular sciences · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Yao ChenHunan Key Laboratory of Ophthalmology, Eye Center of Xiangya Hospital, Central South University, National Clinical Medical Center for Geriatric Diseases of Xiangya Hospital, Changsha, China.
Xiaoqin LuDepartment of Medicine, James Graham Brown Cancer Center, Birth Defects Center, University of Louisville School of Medicine, Louisville, KY, USA.
Ling GaoDepartment of Ophthalmology, Second Xiangya Hospital, Central South University, Changsha, China. gaoling66@gmail.com.
Douglas C DeanDepartment of Medicine, James Graham Brown Cancer Center, Birth Defects Center, University of Louisville School of Medicine, Louisville, KY, USA. dcdean01@louisville.edu.
Yongqing LiuDepartment of Medicine, James Graham Brown Cancer Center, Birth Defects Center, University of Louisville School of Medicine, Louisville, KY, USA. y0liu016@louisville.edu.ORCID http://orcid.org/0000-0003-1090-0865
University of Louisville · USCentral South University · CN

Funding

Molecular Determinants of Developmental DefectsP20GM103453 · NIGMS · UNIVERSITY OF LOUISVILLE · PI GREENE, ROBERT M · 2012 to 2012
$1.7M
NIGMS NIH HHS P20 GM103453
6 · The paper itself

Abstract

purposeThe mechanism underlying cancer heterogeneity and plasticity remains elusive, in spite of the fact that multiple hypotheses have been put forward. We intended to clarify this heterogeneity in uveal melanoma (UM) by looking for evidence of cancer stem cell involvement and a potential role of ZEB1 in cancer cell plasticity.

methodsSpheroids derived from human UM cells as well as xenograft tumors in nude mice were dissected for signs of heterogeneity and plasticity. Two human UM cell lines were studied: the epithelioid type C918 cell line and the spindle type OCM1 cell line. We knocked down ZEB1 in both cell lines to investigate its involvement in the regulation of stem-like cell formation and vascularization by qRT-PCR, immunohistochemistry, flow cytometry, electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) assays.

resultsWe found that a small side population (SP) in OCM1 showed stem cell-like properties such as heterogeneity, remote dissemination and nuclear dye exclusion after spheroid formation in vitro. ZEB1 regulated UM stem cell generation indirectly by promoting cell proliferation to form large size tumors in vivo and spheroid in vitro, and directly by binding to stemness genes such as TERT and ABCB1. In addition, we found that ZEB1 participates in vasculogenic mimicry system formation through the regulation of CD34 and VE-cadherin expression.

conclusionsFrom our data we conclude that cancer stem cells may contribute to UM heterogeneity and plasticity and that ZEB1 may play a regulatory role in it.

Indexed as

MelanomaUveal NeoplasmsAnimalsCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticHumansMiceMice, NudeUveal MelanomaCancer stem cellSpheroidUveal melanomaVasculogenic mimicryZEB1

Identifiers

PMID35404029
PMCPMC9050762
OpenAlexW4223414425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.